Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2018

Nov 20, 2018

33003_dirs_2018-11-20_0cb5b7fe-3fb5-4dbb-9afb-62016f416e24.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2018-11-16

Reporting Person: Zarur Juan Andrey (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-11-16 Common Stock S 100 $35.00 Disposed 691105 Direct

Footnotes

F1: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018.